Unlike earlier compounds that focused on a narrower range of metabolic pathways, Retatrutide has attracted global attention because of the substantial outcomes reported during major clinical trials
Taylor recommends the right one for your goals and history at intake
Another meta-analysis, which looked at relevant data from multiple clinical studies, estimated that 40-70% of people on GLP-1 drugs will experience nausea at some point while taking the medication
Int J Mol Sci 2022;23
36 In some situations, the specific risk factor may have been mitigated and is no longer a concern (e.g., a high triglyceride level that is now within normal range, previous excess alcohol use in a patient who is currently sober, history of gallstones since resolved by cholecystectomy)
Consistency with rotation Whichever site you choose, it should be part of a structured rotation plan (discussed further below) to prevent tissue damage over time